Trial Search Results

Early Screening and Treatment of Women With Prediabetes in Pregnancy

The investigators hope to learn whether treatment with medical nutrition therapy (MNT) for pregnant women with prediabetes decreases the rate and severity of impaired glucose tolerance later in pregnancy and improves perinatal outcomes. Given the rising rates of obesity and diabetes in this country even among young women and the adverse affects of diabetes of pregnant women and their infants, the investigators feel that it is important to not only identify women at high risk for diabetes early in pregnancy but determine the appropriate management strategy

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: Santa Clara Valley Medical Center

Stanford Investigator(s):

Intervention(s):

  • Other: Minimum intervention control group
  • Other: Treatment for glucose intolerance

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Age 18 or older

   - Singleton pregnancy

   - Prenatal care established at less than 14 weeks

   - A1C 5.7-6.4%

   - Delivery planned at Lucille Packard Children's Hospital at Stanford University (LPCH)
   or Santa Clara Valley Medical Center (SVMC)

Exclusion Criteria:

   - preexisting diabetes or chronic steroid use

   - known major fetal anomalies

Ages Eligible for Study

18 Years - 55 Years

Genders Eligible for Study

Female

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Sarah S Osmundson, MD
312-479-3130
Not Recruiting